UBS Reiterates Neutral Rating on Edwards Lifesciences (EW) Ahead of Investor Day
Tweet Send to a Friend
UBS analyst Danielle Antalffy reiterated a Neutral rating and $90.00 price target on Edwards Lifesciences (NYSE: EW).The analyst commented, "Ahead ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
